Tripp Keber, CEO of Dixie Brands
In Episode 12 of Investing in Cannabis, Brandon David interviews Dixie Brands CEO Tripp Keber on a visit to California, where the company recently expanded with a partnership with Altai Brands (Indus Holding). The interview covers Tripp’s background, his desire to be in front of legalization in California, the products initially on the market there (150 SKUs), the shift towards ingestion rather than smoking, the elevation of the product line, the investment in packaging (a huge challenge!), collaboration with regulators, the popularity of Synergy (1:1 THC/CBD sublingual), and the wild success with woman’s sexuality product, Foria, which Dixie manufactures in Colorado Tripp also discusses the importance of lab testing Dixie’s products (speaking very favorably of Steep Hill), the talent of his team, and two new companies recently launched, including Aceso (hemp-based products for health and wellness) and Therabis (hemp-based products for pets). He also shares his favorable view on technology (including MassRoots, which he expects will be a “darling of Wall Street”) and his investment in Canna Security America.
Listen to “Investing in Cannabis – Episode 12: Tripp Keber, CEO of Dixie Brands”:
https://soundcloud.com/investing-in-cannabis-show/episode-12-tripp-keber-ceo-of-dixie-brands
